Economic evaluation of cholinesterase inhibitor therapy for dementia: comparison of Alzheimer's disease and Dementia with Lewy bodies.
OBJECTIVE: To assess the cost effectiveness of cholinesterase inhibitor (ChEI) treatment in patients with Alzheimer's disease (AD) and Dementia with Lewy bodies (DLB). METHOD: We used 4-month open label follow-up data from routine memory clinic patients. There were 852 patients with AD and 112...
Príomhchruthaitheoirí: | Gustavsson, A, Van Der Putt, R, Jönsson, L, Mcshane, R |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2009
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
de réir: Rolinski, M, et al.
Foilsithe / Cruthaithe: (2012) -
Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies.
de réir: Ballard, C, et al.
Foilsithe / Cruthaithe: (2007) -
Cholinesterase inhibitor treatment increases phosphotau accumulation in Alzheimer's disease but reduces A beta in dementia with Lewy bodies
de réir: Chalmers, K, et al.
Foilsithe / Cruthaithe: (2008) -
Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology.
de réir: McShane, R, et al.
Foilsithe / Cruthaithe: (2001) -
Depression in dementia with Lewy bodies: A comparison with Alzheimer's disease.
de réir: Pai-Yi Chiu, et al.
Foilsithe / Cruthaithe: (2017-01-01)